XBIO vs. VT
Compare and contrast key facts about Xenetic Biosciences, Inc. (XBIO) and Vanguard Total World Stock ETF (VT).
VT is a passively managed fund by Vanguard that tracks the performance of the FTSE Global All Cap Index. It was launched on Jun 24, 2008.
Performance
XBIO vs. VT - Performance Comparison
Loading graphics...
XBIO vs. VT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBIO Xenetic Biosciences, Inc. | 29.95% | -45.61% | 15.65% | 21.01% | -77.90% | -36.76% | 41.67% | -92.68% | -14.54% | -55.37% |
VT Vanguard Total World Stock ETF | -0.74% | 22.43% | 16.49% | 22.02% | -18.00% | 18.27% | 16.59% | 26.81% | -9.76% | 24.50% |
Returns By Period
In the year-to-date period, XBIO achieves a 29.95% return, which is significantly higher than VT's -0.74% return. Over the past 10 years, XBIO has underperformed VT with an annualized return of -45.52%, while VT has yielded a comparatively higher 11.64% annualized return.
XBIO
- 1D
- 5.22%
- 1M
- 10.59%
- YTD
- 29.95%
- 6M
- -9.03%
- 1Y
- 14.63%
- 3Y*
- -11.44%
- 5Y*
- -33.07%
- 10Y*
- -45.52%
VT
- 1D
- 0.99%
- 1M
- -4.72%
- YTD
- -0.74%
- 6M
- 1.90%
- 1Y
- 22.33%
- 3Y*
- 17.24%
- 5Y*
- 9.43%
- 10Y*
- 11.64%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBIO vs. VT — Risk / Return Rank
XBIO
VT
XBIO vs. VT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xenetic Biosciences, Inc. (XBIO) and Vanguard Total World Stock ETF (VT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XBIO | VT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.09 | 1.30 | -1.21 |
Sortino ratioReturn per unit of downside risk | 1.78 | 1.90 | -0.13 |
Omega ratioGain probability vs. loss probability | 1.22 | 1.28 | -0.07 |
Calmar ratioReturn relative to maximum drawdown | 0.10 | 1.92 | -1.82 |
Martin ratioReturn relative to average drawdown | 0.15 | 8.83 | -8.68 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XBIO | VT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.09 | 1.30 | -1.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.31 | 0.59 | -0.90 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.34 | 0.68 | -1.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.32 | 0.40 | -0.72 |
Correlation
The correlation between XBIO and VT is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
XBIO vs. VT - Dividend Comparison
XBIO has not paid dividends to shareholders, while VT's dividend yield for the trailing twelve months is around 1.80%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XBIO Xenetic Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VT Vanguard Total World Stock ETF | 1.80% | 1.82% | 1.95% | 2.08% | 2.20% | 1.82% | 1.66% | 2.32% | 2.53% | 2.11% | 2.39% | 2.45% |
Drawdowns
XBIO vs. VT - Drawdown Comparison
The maximum XBIO drawdown since its inception was -99.95%, which is greater than VT's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for XBIO and VT.
Loading graphics...
Drawdown Indicators
| XBIO | VT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.95% | -50.27% | -49.68% |
Max Drawdown (1Y)Largest decline over 1 year | -80.50% | -11.84% | -68.66% |
Max Drawdown (5Y)Largest decline over 5 years | -96.19% | -26.38% | -69.81% |
Max Drawdown (10Y)Largest decline over 10 years | -99.83% | -34.24% | -65.59% |
Current DrawdownCurrent decline from peak | -99.93% | -5.97% | -93.96% |
Average DrawdownAverage peak-to-trough decline | -91.28% | -7.08% | -84.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 52.52% | 2.57% | +49.95% |
Volatility
XBIO vs. VT - Volatility Comparison
Xenetic Biosciences, Inc. (XBIO) has a higher volatility of 30.65% compared to Vanguard Total World Stock ETF (VT) at 6.18%. This indicates that XBIO's price experiences larger fluctuations and is considered to be riskier than VT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XBIO | VT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.65% | 6.18% | +24.47% |
Volatility (6M)Calculated over the trailing 6-month period | 116.33% | 10.00% | +106.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 169.13% | 17.26% | +151.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 108.22% | 15.98% | +92.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 134.13% | 17.20% | +116.93% |